BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9735330)

  • 1. Resveratrol arrests the cell division cycle at S/G2 phase transition.
    Ragione FD; Cucciolla V; Borriello A; Pietra VD; Racioppi L; Soldati G; Manna C; Galletti P; Zappia V
    Biochem Biophys Res Commun; 1998 Sep; 250(1):53-8. PubMed ID: 9735330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol, a chemopreventive agent, disrupts the cell cycle control of human SW480 colorectal tumor cells.
    Delmas D; Passilly-Degrace P; Jannin B; Cherkaoui Malki M; Latruffe N
    Int J Mol Med; 2002 Aug; 10(2):193-9. PubMed ID: 12119558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells.
    Ahmad N; Adhami VM; Afaq F; Feyes DK; Mukhtar H
    Clin Cancer Res; 2001 May; 7(5):1466-73. PubMed ID: 11350919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines.
    Joe AK; Liu H; Suzui M; Vural ME; Xiao D; Weinstein IB
    Clin Cancer Res; 2002 Mar; 8(3):893-903. PubMed ID: 11895924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Grape polyphenol resveratrol and the related molecule 4-hydroxystilbene induce growth inhibition, apoptosis, S-phase arrest, and upregulation of cyclins A, E, and B1 in human SK-Mel-28 melanoma cells.
    Larrosa M; Tomás-Barberán FA; Espín JC
    J Agric Food Chem; 2003 Jul; 51(16):4576-84. PubMed ID: 14705880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemopreventive agent resveratrol, a natural product derived from grapes, reversibly inhibits progression through S and G2 phases of the cell cycle in U937 cells.
    Park JW; Choi YJ; Jang MA; Lee YS; Jun DY; Suh SI; Baek WK; Suh MH; Jin IN; Kwon TK
    Cancer Lett; 2001 Feb; 163(1):43-9. PubMed ID: 11163107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol induces prostate cancer cell entry into s phase and inhibits DNA synthesis.
    Kuwajerwala N; Cifuentes E; Gautam S; Menon M; Barrack ER; Reddy GP
    Cancer Res; 2002 May; 62(9):2488-92. PubMed ID: 11980638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol increases nitric oxide synthase, induces accumulation of p53 and p21(WAF1/CIP1), and suppresses cultured bovine pulmonary artery endothelial cell proliferation by perturbing progression through S and G2.
    Hsieh TC; Juan G; Darzynkiewicz Z; Wu JM
    Cancer Res; 1999 Jun; 59(11):2596-601. PubMed ID: 10363980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol inhibits cell cycle progression in U937 cells.
    Castello L; Tessitore L
    Oncol Rep; 2005 Jan; 13(1):133-7. PubMed ID: 15583814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autographa californica nucleopolyhedrovirus infection results in Sf9 cell cycle arrest at G2/M phase.
    Braunagel SC; Parr R; Belyavskyi M; Summers MD
    Virology; 1998 Apr; 244(1):195-211. PubMed ID: 9581791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G2/M cell cycle arrest and induction of apoptosis by a stilbenoid, 3,4,5-trimethoxy-4'-bromo-cis-stilbene, in human lung cancer cells.
    Lee EJ; Min HY; Joo Park H; Chung HJ; Kim S; Nam Han Y; Lee SK
    Life Sci; 2004 Oct; 75(23):2829-39. PubMed ID: 15464834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA damage and p53 induction do not cause ZD1694-induced cell cycle arrest in human colon carcinoma cells.
    Matsui SI; Arredondo MA; Wrzosek C; Rustum YM
    Cancer Res; 1996 Oct; 56(20):4715-23. PubMed ID: 8840989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol induces apoptosis and differentiation in acute promyelocytic leukemia (NB4) cells.
    Cao Y; Wang F; Liu HY; Fu ZD; Han R
    J Asian Nat Prod Res; 2005 Aug; 7(4):633-41. PubMed ID: 16087638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol, a natural stilbene in grapes and wine, enhances intraphagocytosis in human promonocytes: a co-factor in antiinflammatory and anticancer chemopreventive activity.
    Bertelli AA; Ferrara F; Diana G; Fulgenzi A; Corsi M; Ponti W; Ferrero ME; Bertelli A
    Int J Tissue React; 1999; 21(4):93-104. PubMed ID: 10761539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol inhibits cell proliferation and induces apoptosis of human breast carcinoma MCF-7 cells.
    Kim YA; Choi BT; Lee YT; Park DI; Rhee SH; Park KY; Choi YH
    Oncol Rep; 2004 Feb; 11(2):441-6. PubMed ID: 14719081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maitotoxin, a calcium channel activator, inhibits cell cycle progression through the G1/S and G2/M transitions and prevents CDC2 kinase activation in GH4C1 cells.
    Van Dolah FM; Ramsdell JS
    J Cell Physiol; 1996 Jan; 166(1):49-56. PubMed ID: 8557775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective growth inhibition of human leukemia and human lymphoblastoid cells by resveratrol via cell cycle arrest and apoptosis induction.
    Lee SK; Zhang W; Sanderson BJ
    J Agric Food Chem; 2008 Aug; 56(16):7572-7. PubMed ID: 18656932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of the retinoblastoma (pRb)-E2F/DP pathway during antiproliferative effects of resveratrol in human epidermoid carcinoma (A431) cells.
    Adhami VM; Afaq F; Ahmad N
    Biochem Biophys Res Commun; 2001 Nov; 288(3):579-85. PubMed ID: 11676482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phorbol ester-induced monocytic differentiation is associated with G2 delay and down-regulation of cdc25 expression.
    Hass R; Gunji H; Hirano M; Weichselbaum R; Kufe D
    Cell Growth Differ; 1993 Mar; 4(3):159-66. PubMed ID: 8466854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanomolar level of resveratrol (trans-3,5,4'-trihydroxystilbene) is required, but is not sufficient, to inhibit the growth of human monocytoid tumor cells through an apoptotic-like mechanism.
    Corsi MM; Ponti W; Ferrara F; Venditti A; Malavazos A; Ruscica M; Mihali D; Diana GM; Paraboni L; Bertelli AA
    Drugs Exp Clin Res; 2002; 28(6):235-42. PubMed ID: 12776577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.